Chemoembolization related to good survival for selected patients with hepatocellular carcinoma invading segmental portal vein.
Jin Hyoung KimJu Hyun ShimHyun-Ki YoonHeung-Kyu KoJong Woo KimDong Il GwonPublished in: Liver international : official journal of the International Association for the Study of the Liver (2018)
TACE was well-tolerated and effective in selected patients with HCC with segmental PVTT. We found that four risk factors were associated with decreased length of patient survival after TACE: a major tumour burden (up-to-11 criteria out), extrahepatic spread, Child-Pugh class B liver function and nonregression to TACE. TACE may not be recommended for HCC patients with segmental PVTT with 2-4 risk factors because of poor survival outcome.
Keyphrases